Intraocular Pressure Elevation Following Intravitreal Injection with Antivascular Endothelial Growth Factor

As the prevalence of both glaucoma and AMD increase with age, there is a considerable chance of having glaucoma in patients who develop CNV in eyes with age-related macular degeneration. This review discusses in great detail the impact of VEGF agents on IOP in terms of both, short-term elevation and long-term effects